Table 2.
Variable | HR | (95% CI) | P value | HR | (95% CI) | P value |
---|---|---|---|---|---|---|
Univariable | Multivariable | |||||
Tumor size | ||||||
≤20 vs >20 | 1,52 | (1.19 - 1.93) | 0,001 | 1,39 | (0.98 - 1.98) | 0,068 |
NHG | ||||||
1, 2 vs 3 | 1,62 | (1.19 - 2.19) | 0,002 | 1,55 | (1.07 - 2.25) | 0,021 |
Nodal metastasis | ||||||
- vs + | 1,31 | (1.02 - 1.69) | 0,035 | 1,71 | (1.18 - 2.47) | 0,005 |
ER | ||||||
- vs + | 0,50 | (0.33 - 0.74) | 0,000 | 0,60 | (0.37 - 0.97) | 0,037 |
CD3 | ||||||
low vs high | 2,61 | (1.57 - 4.32) | 0,000 | 1,77 | (1.01 - 3.13) | 0,048 |
FOXP3 | ||||||
low vs high | 1,26 | (0.91 - 1.74) | 0,16 |
Abbreviations: HR hazard ratio, CI confidential interval, NHG Nottingham histologic grade, ER estrogen receptor, PR progesterone receptor. CD3 indicates infiltration level of T lymphocytes (low 0, 1, 2 vs high 3) in primary tumor. FOXP3 indicates infiltration level of regulatory T lymphocytes (low 0 vs high 1, 2, 3). Spearman correlation, two-tailed P value. Bold indicates P value < 0.05